CMS

News

CMS has extended the deadline for its Medicaid drug pricing pilot, GENEROUS, to "provide interested drug manufacturers more opportunity to join."

News

The US federal government has named the next 15 big-selling medicines that will be subject to Medicare pricing negotiations.

News

CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.

News

CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.

News

The FDA is rolling out a pilot programme that could make it easier to bring digital health technologies for chronic diseases to market more quickly.

News

The CMS has revealed the prices for the second batch of 15 drugs going through Medicare's negotiation process, promising net savings of 44% on 2024.